Evidence map›Paper›PMID 27887591›Full record

Trial reportBMC infectious diseases2016

A prospective cohort study to assess seroprevalence, incidence, knowledge, attitudes and practices, willingness to pay for vaccine and related risk factors in dengue in a high incidence setting.

Ruth Aralí Martínez-Vega, Alfonso J Rodriguez-Morales, Yalil Tomás Bracho-Churio, Mirley Enith Castro-Salas, Fredy Galvis-Ovallos, Ronald Giovanny Díaz-Quijano, María Lucrecia Luna-González, Jaime E Castellanos, José Ramos-Castañeda, Fredi Alexander Diaz-Quijano

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in BMC infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Ruth Aralí Martínez-VegaOrganización Latinoamericana para el Fomento de la Investigación en Salud, Bucaramanga, Santander, Colombia.
Alfonso J Rodriguez-MoralesOrganización Latinoamericana para el Fomento de la Investigación en Salud, Bucaramanga, Santander, Colombia.
Yalil Tomás Bracho-ChurioOrganización Latinoamericana para el Fomento de la Investigación en Salud, Bucaramanga, Santander, Colombia.
Mirley Enith Castro-SalasOrganización Latinoamericana para el Fomento de la Investigación en Salud, Bucaramanga, Santander, Colombia.
Fredy Galvis-OvallosOrganización Latinoamericana para el Fomento de la Investigación en Salud, Bucaramanga, Santander, Colombia.
Ronald Giovanny Díaz-QuijanoOrganización Latinoamericana para el Fomento de la Investigación en Salud, Bucaramanga, Santander, Colombia.
María Lucrecia Luna-GonzálezOrganización Latinoamericana para el Fomento de la Investigación en Salud, Bucaramanga, Santander, Colombia.
Jaime E CastellanosGrupo de Virología, Universidad El Bosque, Bogotá, Colombia.
José Ramos-CastañedaCentro de Investigaciones sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.
Fredi Alexander Diaz-QuijanoDepartment of Epidemiology, Universidade de São Paulo, São Paulo, São Paulo, Brazil. frediazq@msn.com.
Instituto Nacional de Salud Pública · MXTechnological University of Pereira · COUniversidade de São Paulo · BRUniversidad El Bosque · COUniversity of Santander · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDengue is one of the most important vector-borne diseases in the world, causing significant morbidity and economic impact. In Colombia, dengue is a major public health problem. Departments of La Guajira, Cesar and Magdalena are dengue endemic areas. The objective of this research is to determine the seroprevalence and the incidence of dengue virus infection in the participating municipalities from these Departments, and also establish the association between individual and housing factors and vector indices with seroprevalence and incidence. We will also assess knowledge, attitudes and practices, and willingness-to-pay for dengue vaccine.

methodsA cohort study will be assembled with a clustered multistage sampling in 11 endemic municipalities. Approximately 1000 homes will be visited to enroll people older than one year who living in these areas, who will be followed for 1 year. Dengue virus infections will be evaluated using IgG indirect ELISA and IgM and IgG capture ELISA. Additionally, vector indices will be measured, and adult mosquitoes will be captured with aspirators. Ovitraps will be used for continuous estimation of vector density. DISCUSSION: This research will generate necessary knowledge to design and implement strategies with a multidimensional approach that reduce dengue morbidity and mortality in La Guajira and other departments from Colombian Caribbean.

Indexed as

Health Knowledge, Attitudes, PracticeAdolescentAdultAgedAged, 80 and overChildChild, PreschoolClinical ProtocolsColombiaCross-Sectional StudiesDengueDengue VaccinesEnzyme-Linked Immunosorbent AssayFemaleFollow-Up StudiesHealth Services Needs and DemandDengue VaccinesColombiaDengueIncidenceKnowledgeRisk factorsSeroprevalenceVaccines

Identifiers

PMID27887591
PMCPMC5124319
OpenAlexW2557063573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.